Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children
Authors:
- 22 February 2023
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 151 (6) , 1558-1565.e6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trialJournal of Allergy and Clinical Immunology, 2013
- Allergic Reactions to Foods in Preschool-Aged Children in a Prospective Observational Food Allergy StudyPediatrics, 2012
- The natural history of persistent peanut allergyAnnals of Allergy, Asthma & Immunology, 2012
- Exploring quality of life in families of children living with and without a severe food allergyAppetite, 2011
- The Prevalence, Severity, and Distribution of Childhood Food Allergy in the United StatesPediatrics, 2011
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic responseJournal of Allergy and Clinical Immunology, 2011
- Sublingual immunotherapy for peanut allergy: Clinical and immunologic evidence of desensitizationJournal of Allergy and Clinical Immunology, 2011
- Management of nut allergy influences quality of life and anxiety in children and their mothersPediatric Allergy and Immunology, 2010
- Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007Journal of Allergy and Clinical Immunology, 2007
- PrefaceJournal of Allergy and Clinical Immunology, 2007